Periodontitis is a painful and destructive dental disease caused by bacteria that induce inflammation, leading to the loss of gums surrounding teeth. As one of the most common dental diseases affecting a large number of the population, researchers have designed a new stem cell-based therapy to treat it.
A clinical trial in Toronto, Canada has demonstrated that a single injection of MSCs (mesenchymal stem cells) can safely reduce pain and improve quality of patients with late-stage osteoarthritis of the knee.
Scientists at Future Health Biobank have provided samples of umbilical cord mesenchymal stem cells (MSCs), to aid pioneering research into the regeneration of tooth dentin and bone.
In 2016, Kris Boesen suffered a devastating cervical spine injury when he was just 20 years old. The injury happened after a serious car accident in Bakersfield, USA, which left him paralysed from the neck down. It was expected that he would remain paralysed for life.
Phase I/II clinical trials have investigated the benefits of stem cell therapy for chronic paraplegia (spinal cord injury), using a drug manufactured with patients’ own stem cells.
A baby girl, Zhao Jiaxin, has become the first child in China to receive a cord blood stem cell transplant to cure an inherited type of Irritable Bowel Disease.
For the first time, researchers have transformed human stem cells into mature insulin-producing cells. The breakthrough could lead us a step closer to developing a cure for Type 1 diabetes.
